1. Home
  2. MFA vs IOVA Comparison

MFA vs IOVA Comparison

Compare MFA & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MFA
  • IOVA
  • Stock Information
  • Founded
  • MFA 1997
  • IOVA 2007
  • Country
  • MFA United States
  • IOVA United States
  • Employees
  • MFA N/A
  • IOVA N/A
  • Industry
  • MFA Real Estate Investment Trusts
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MFA Real Estate
  • IOVA Health Care
  • Exchange
  • MFA Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • MFA 930.2M
  • IOVA 975.1M
  • IPO Year
  • MFA N/A
  • IOVA N/A
  • Fundamental
  • Price
  • MFA $8.98
  • IOVA $2.30
  • Analyst Decision
  • MFA Buy
  • IOVA Buy
  • Analyst Count
  • MFA 7
  • IOVA 11
  • Target Price
  • MFA $11.00
  • IOVA $10.80
  • AVG Volume (30 Days)
  • MFA 1.1M
  • IOVA 18.5M
  • Earning Date
  • MFA 11-06-2025
  • IOVA 11-06-2025
  • Dividend Yield
  • MFA 16.05%
  • IOVA N/A
  • EPS Growth
  • MFA N/A
  • IOVA N/A
  • EPS
  • MFA 0.86
  • IOVA N/A
  • Revenue
  • MFA $274,911,000.00
  • IOVA $250,425,000.00
  • Revenue This Year
  • MFA N/A
  • IOVA $65.15
  • Revenue Next Year
  • MFA $14.85
  • IOVA $58.47
  • P/E Ratio
  • MFA $10.43
  • IOVA N/A
  • Revenue Growth
  • MFA N/A
  • IOVA 175.62
  • 52 Week Low
  • MFA $7.85
  • IOVA $1.64
  • 52 Week High
  • MFA $12.60
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • MFA 42.09
  • IOVA 57.31
  • Support Level
  • MFA $8.80
  • IOVA $1.76
  • Resistance Level
  • MFA $9.26
  • IOVA $2.20
  • Average True Range (ATR)
  • MFA 0.17
  • IOVA 0.16
  • MACD
  • MFA 0.02
  • IOVA -0.01
  • Stochastic Oscillator
  • MFA 35.87
  • IOVA 76.00

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: